Understanding the mechanisms behind effective anti-tumor immune responses, including antigen processing and presentation, migration, and cytotoxic capacity, will require robust numbers of tumor-specific CD8+ T cells, for which the GL261-Quad model will again provide a powerful tool. The gene discussed is CD8A; the disease is neoplasm.